| Dr Linda M Nagy, MD | |
|
215 N Main St, Vamc 116a, White River Junction, VT 05009-0001 | |
| (802) 295-9363 | |
| (802) 296-6389 |
| Full Name | Dr Linda M Nagy |
|---|---|
| Gender | Female |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 215 N Main St, White River Junction, Vermont |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366552853 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 042-0009667 (Vermont) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Linda M Nagy, MD 215 N Main St, Vamc 116a, White River Junction, VT 05009-0001 Ph: (802) 295-9363 | Dr Linda M Nagy, MD 215 N Main St, Vamc 116a, White River Junction, VT 05009-0001 Ph: (802) 295-9363 |
News Archive
Life Sciences Minister George Freeman today (16 December) announced £10 million investment in five new research centres around the UK that will explore how mathematics and statistics can help clinicians to tackle serious health challenges such as cancer, heart disease and antibiotic resistant bacteria.
Novel vaccine technologies are critical to improving the public health response to infectious disease threats that continually emerge and re-emerge, according to scientists at the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.
'I won't be able to cope with my pain if I don't sleep well' - research from the University of Warwick reveals that the way chronic pain patients think about pain and sleep leads to insomnia and poor management of pain.
The U.S. Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee held a joint meeting primarily focused on reviewing the cardiovascular safety of rosiglitazone, as presented by the FDA and GlaxoSmithKline. Following this two day discussion, Takeda Pharmaceuticals North America, Inc. ("Takeda") underscores its position that ACTOS (pioglitazone HCl) offers an established safety profile regarding the risk of CV events in people living with type 2 diabetes.
› Verified 9 days ago
Dr. John L Hammel, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 215 N Main St, Va Medical Center, Mental Health Department, White River Junction, VT 05009 Phone: 802-295-9363 Fax: 802-296-6342 | |
Dr. Andrew S. Pomerantz, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 215 N Main St, Mental Health 116a, White River Junction, VT 05001 Phone: 802-295-9363 Fax: 802-296-6389 | |
Stephen Bettwieser, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 215 N Main St, White River Junction, VT 05009 Phone: 802-295-9363 Fax: 802-296-5188 | |
Lisa Ann Lambert, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 215 N Main St, White River Junction, VT 05009 Phone: 802-295-9363 | |
Melissa Moate Ley-thomson, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 215 N Main St, White River Junction, VT 05009 Phone: 802-295-9363 | |
Dr. Jonathan Carl Schwartz, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 215 N Main St, White River Junction, VT 05009 Phone: 802-295-9363 Fax: 802-296-6342 |